|
Volumn 42, Issue 3, 2001, Pages 393-398
|
Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Acute lymphoblastic leukemia; Childhood; Prognosis
|
Indexed keywords
ASPARAGINASE;
CD19 ANTIGEN;
CD20 ANTIGEN;
CD24 ANTIGEN;
CD3 ANTIGEN;
CD45 ANTIGEN;
COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
AGE;
ANTIGEN EXPRESSION;
ARTICLE;
BLAST CELL;
CANCER SURVIVAL;
CHILD;
CHILDHOOD LEUKEMIA;
CHROMOSOME NUMBER;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DIPLOIDY;
FLUORESCENCE;
GENDER;
HIGH RISK PATIENT;
HUMAN;
IMMUNOREACTIVITY;
KARYOTYPE;
LEUKOCYTE COUNT;
LYMPHOBLAST;
MAJOR CLINICAL STUDY;
PRE B LYMPHOCYTE;
PRIORITY JOURNAL;
PROGNOSIS;
STATISTICAL ANALYSIS;
T CELL LEUKEMIA;
|
EID: 0034909668
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.3109/10428190109064596 Document Type: Article |
Times cited : (16)
|
References (14)
|